Clinical Trial Update: SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance [NA]

View source ↗

Summary

A feasibility trial named SURVEY-CNS is randomizing women and men with HER2-positive metastatic breast cancer to central nervous system surveillance versus no s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Royal College of Surgeons, Ireland | Conditions: Breast Cancer, HER2-Positive Metastatic Breast Cancer | NA | Status: RECRUITING